Notably, when considering APOE carriers among MCI subjects who transitioned to AD, it was observed that the proportion of APOE ε2 carriers within each subtype remained below 5%, whereas the prevalence of APOE ε4 carriers exceeded 60% (Table 4). The gene discussed is APOE; the disease is Alzheimer disease.